Uso de bifosfonatos en la enfermedad renal crónica
Use of bisphosphonates in chronic kidney disease
Leído
77246
Vecesse ha leído el artículo
6723
Total PDF
70523
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 152 | 22 | 174 |
| 2025 5 | 796 | 76 | 872 |
| 2025 4 | 825 | 55 | 880 |
| 2025 3 | 907 | 85 | 992 |
| 2025 2 | 807 | 51 | 858 |
| 2025 1 | 919 | 59 | 978 |
| 2024 12 | 689 | 50 | 739 |
| 2024 11 | 818 | 101 | 919 |
| 2024 10 | 855 | 81 | 936 |
| 2024 9 | 772 | 73 | 845 |
| 2024 8 | 777 | 91 | 868 |
| 2024 7 | 805 | 71 | 876 |
| 2024 6 | 612 | 120 | 732 |
| 2024 5 | 725 | 148 | 873 |
| 2024 4 | 851 | 70 | 921 |
| 2024 3 | 659 | 70 | 729 |
| 2024 2 | 707 | 69 | 776 |
| 2024 1 | 840 | 66 | 906 |
| 2023 12 | 693 | 69 | 762 |
| 2023 11 | 782 | 96 | 878 |
| 2023 10 | 773 | 101 | 874 |
| 2023 9 | 720 | 79 | 799 |
| 2023 8 | 697 | 77 | 774 |
| 2023 7 | 663 | 124 | 787 |
| 2023 6 | 704 | 95 | 799 |
| 2023 5 | 606 | 92 | 698 |
| 2023 4 | 533 | 94 | 627 |
| 2023 3 | 627 | 93 | 720 |
| 2023 2 | 494 | 91 | 585 |
| 2022 1 | 393 | 84 | 477 |
| 2022 12 | 390 | 88 | 478 |
| 2022 11 | 474 | 94 | 568 |
| 2022 10 | 458 | 104 | 562 |
| 2022 9 | 383 | 73 | 456 |
| 2022 8 | 413 | 92 | 505 |
| 2022 7 | 415 | 93 | 508 |
| 2022 6 | 468 | 97 | 565 |
| 2022 5 | 403 | 101 | 504 |
| 2022 4 | 463 | 121 | 584 |
| 2022 3 | 504 | 107 | 611 |
| 2022 2 | 374 | 82 | 456 |
| 2021 1 | 392 | 75 | 467 |
| 2021 12 | 396 | 81 | 477 |
| 2021 11 | 375 | 92 | 467 |
| 2021 10 | 378 | 98 | 476 |
| 2021 9 | 376 | 87 | 463 |
| 2021 8 | 327 | 88 | 415 |
| 2021 7 | 237 | 48 | 285 |
| 2021 6 | 293 | 87 | 380 |
| 2021 5 | 302 | 103 | 405 |
| 2021 4 | 662 | 163 | 825 |
| 2021 3 | 497 | 85 | 582 |
| 2021 2 | 330 | 61 | 391 |
| 2020 1 | 306 | 44 | 350 |
| 2020 12 | 390 | 45 | 435 |
| 2020 11 | 362 | 43 | 405 |
| 2020 10 | 279 | 43 | 322 |
| 2020 9 | 328 | 58 | 386 |
| 2020 8 | 316 | 34 | 350 |
| 2020 7 | 332 | 44 | 376 |
| 2020 6 | 368 | 41 | 409 |
| 2020 5 | 462 | 52 | 514 |
| 2020 4 | 464 | 51 | 515 |
| 2020 3 | 358 | 42 | 400 |
| 2020 2 | 378 | 52 | 430 |
| 2020 1 | 390 | 73 | 463 |
| 2019 12 | 350 | 30 | 380 |
| 2019 11 | 426 | 63 | 489 |
| 2019 10 | 565 | 48 | 613 |
| 2019 9 | 663 | 52 | 715 |
| 2019 8 | 413 | 77 | 490 |
| 2019 7 | 527 | 60 | 587 |
| 2019 6 | 391 | 72 | 463 |
| 2019 5 | 465 | 41 | 506 |
| 2019 4 | 477 | 76 | 553 |
| 2019 3 | 363 | 90 | 453 |
| 2019 2 | 297 | 77 | 374 |
| 2019 1 | 334 | 55 | 389 |
| 2018 12 | 378 | 64 | 442 |
| 2018 11 | 554 | 49 | 603 |
| 2018 10 | 492 | 30 | 522 |
| 2018 9 | 523 | 23 | 546 |
| 2018 8 | 537 | 27 | 564 |
| 2018 7 | 487 | 23 | 510 |
| 2018 6 | 491 | 25 | 516 |
| 2018 5 | 508 | 24 | 532 |
| 2018 4 | 432 | 14 | 446 |
| 2018 3 | 308 | 18 | 326 |
| 2018 2 | 285 | 15 | 300 |
| 2018 1 | 287 | 11 | 298 |
| 2017 12 | 268 | 13 | 281 |
| 2017 11 | 332 | 13 | 345 |
| 2017 10 | 286 | 11 | 297 |
| 2017 9 | 311 | 21 | 332 |
| 2017 8 | 288 | 30 | 318 |
| 2017 7 | 277 | 18 | 295 |
| 2017 6 | 279 | 40 | 319 |
| 2017 5 | 359 | 43 | 402 |
| 2017 4 | 450 | 61 | 511 |
| 2017 3 | 577 | 35 | 612 |
| 2017 2 | 663 | 21 | 684 |
| 2016 1 | 309 | 18 | 327 |
| 2016 12 | 333 | 16 | 349 |
| 2016 11 | 429 | 27 | 456 |
| 2016 10 | 412 | 22 | 434 |
| 2016 9 | 646 | 26 | 672 |
| 2016 8 | 866 | 21 | 887 |
| 2016 7 | 502 | 28 | 530 |
| 2016 6 | 361 | 0 | 361 |
| 2016 5 | 370 | 0 | 370 |
| 2016 4 | 316 | 0 | 316 |
| 2016 3 | 256 | 0 | 256 |
| 2016 2 | 266 | 0 | 266 |
| 2015 1 | 245 | 0 | 245 |
| 2015 12 | 258 | 0 | 258 |
| 2015 11 | 274 | 0 | 274 |
| 2015 10 | 258 | 0 | 258 |
| 2015 9 | 213 | 0 | 213 |
| 2015 8 | 219 | 0 | 219 |
| 2015 7 | 283 | 0 | 283 |
| 2015 6 | 197 | 0 | 197 |
| 2015 5 | 323 | 0 | 323 |
| 2015 4 | 99 | 0 | 99 |
| 2015 2 | 13201 | 0 | 13201 |
Mostrar todo
